Algo version: 0.98b
Gan & Lee is listed at the SHH Exchange
Gan & Lee [603087.SS]
SHH Sector: Healthcare Industry:Medical Instruments & Supplies

Is Gan & Lee stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Gan & Lee pays dividends. Last time was Tuesday 18th of June 2024 where the investors holding the stock on Tuesday 18th of June 2024 were paid CNY0.2 per share. Over the last 4 times between 2020 and 2024, Gan & Lee has paid CNY1.4 with an average of CNY0.35 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Gan & Lee 10 years ago, but if you had invested on Monday 29th of June 2020 when the price was CNY65.13, you would have made a loss of CNY-16.83 per share or -25.84%

Yes, the average daily trading liquidity for Gan & Lee is CNY6.71 million. You should therefore be able to get in and out of your positions relatively fast.

Gan & Lee has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 1.72, the company's ability to pay off the debt is good. Gan & Lee has a good net profit margin of 18.89% and should have high tolerances against inflation.

We have calculated the inflation risk for Gan & Lee to be low [0.1 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.